GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Total Stockholders Equity

AdAlta (ASX:1AD) Total Stockholders Equity : A$2.42 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is AdAlta Total Stockholders Equity?

AdAlta's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$2.42 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. AdAlta's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. AdAlta's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.83.


AdAlta Total Stockholders Equity Historical Data

The historical data trend for AdAlta's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdAlta Total Stockholders Equity Chart

AdAlta Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Stockholders Equity
Get a 7-Day Free Trial 7.49 3.70 6.39 5.38 1.91

AdAlta Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.36 5.38 2.71 1.91 2.42

AdAlta  (ASX:1AD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

AdAlta's Book Value per Share for the quarter that ended in Dec. 2023 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

AdAlta's Debt-to-Equity for the quarter that ended in Dec. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AdAlta Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of AdAlta's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


AdAlta (ASX:1AD) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2 Park Drive, Unit 15, Bundoora, VIC, AUS, 3083
AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.

AdAlta (ASX:1AD) Headlines

No Headlines